Sentences with word «biotherapeutic»

The trial is in collaboration with Asterias Biotherapeutics, a biotech company in Fremont, Calif., that devised the stem cell technology.

Genzyme Corp — Data collection and analysis during preformulation of biotherapeutic proteins

All I know is that I am eployed at a big biotherapeutic company in Clayton NC and I endroce Barack Obama with all my energy.

Regulatory optimism from GTC Biotherapeutics, which started a collaboration with New Zealand's AgResearch for animal - produced biosimilars; but pessimism from Basilea, which filed for arbitration against J&J after facing delays with their flagship antibiotic; and

About Blog CSL Behring is a global leader in biotherapeutics for patients with rare diseases.

Five new campus companies have emerged from our research discoveries that focus on biotherapeutic development.

This webcast features: Jamie Freeman, PhD, Product Manager, Horizon Discovery While great strides have been made in increasing the yield of biotherapeutic proteins, these have been achieved mainly through process improvement with a particular focus on media and feed strategies.

Additional authors included Patrizia Murer, Brian J. Schriver, Alexander Bell, Aishwarya Subramanian, Corry E. McDonald, and Howard Cha, of UCSF; Jiahu Wang, PhD, Marie - Claude Bourgeois - Daigneault, PhD, and John C. Bell, PhD, of the Ottawa Hospital Research Institute; and David H. Kirn, MD, Naomi De Silva, PhD, and Caroline J. Breitbach, PhD, of SillaJen Biotherapeutics, Inc. in San Francisco.

«This study represents the first time that DNA vaccines have been used to produce a hyperimmunized response in a human antibody - producing large animal species,» said Eddie Sullivan, chief executive officer of SAB Biotherapeutics, Inc. «Furthermore, the animal studies show that the human antibody is protective in the animal model presented.»

Co-authors besides Reid are Tina Au, Steve Thorne and Daniel Sze of Palo Alto Veteran's Administration Health Care System and Stanford University; W. Michael Korn of the University of California, San Francisco; and David Kirn of Oxford University, Jennerex Biotherapeutics, San Francisco.

A2 Biotherapeutics is an early - stage biotechnology company located in Southern California that develops novel medicines for serious illnesses.

GigaGen is advancing a pipeline of first - in - class biotherapeutics, including novel oncology antibody drug combinations and the world's first recombinant polyclonal hyperimmune gammaglobulin.

Having originally filed an $ 86 - million IPO in 2015 to take Viventia Bio public, Dan sold the company in September 2016 to Eleven Biotherapeutics for just $ 13 million.

• RubrYc Therapeutics, a San Ramon biotherapeutics discovery business, raised $ 10 million in funding.

• EpimAb Biotherapeutics, a Shanghai - based biotech company specializing in bispecific antibodies, raised $ 25 million in Series A. Oriza Seed Capital led the round, and was joined by Decheng Capital, 3E Bioventures Capital and Trend Investment Group.

He also pointed to his firm's 2015 acquisition of early - stage immuno - oncology company cCAM Biotherapeutics.

Just wanted to say that I work at a large biotherapeutic corporation in Clayton NC and I endroce Barack Obama with all my heart.

Northwest Biotherapeutics (OTCBB: NWBO, US) The company is developing a dendritic cell - based cancer vaccines for more than a decade.

A biosimilar biotherapeutic product is similar (but not identical) in terms of quality, safety, and efficacy to an already licensed reference product.

6.5 Fourth Generation Oncolytic Virus Companies 6.5.1 Duke University Start - Up Company 6.5.2 IGNITE Immunotherapy 6.5.3 Oncorus 6.5.4 Replimmune 6.5.5 TILT Biotherapeutics 6.5.6 Turnstone Biologics 6.5.7 Unleash Immuno Oncolytics 6.5.8 ViraTherapeutics 6.5.9 Vyriad 6.5.10 Western Oncolytics

The workshops were given to the Global Biotherapeutics Technologies division.

In 2016, Kruse was selected by Forbes magazine for its 30 - under - 30 in health care, along with Aaron Ring, now at Yale University, who together had founded Ab Initio Biotherapeutics, Inc..

PEGS: The Essential Protein Engineering Summit is one of the industry's most preeminent events that inspires accelerated biotherapeutic protein drug development.

He currently manages an R&D team in conducting bioanalytical method research and development primarily for biotherapeutics using LC - MS technologies.

Acquisitions of NPS Pharmaceuticals, Foresight Biotherapeutics, Lotus Tissue Repair, FerroKin Biosciences and Advanced BioHealing

FP&A business partner to Commercial organization for budget management, reporting, expense analysis, accruals, and financial modeling in support of a joint collaboration biotherapeutic brand.

The dispute involved an appeal to the U.S. District Court by Asterias Biotherapeutics, Inc., (as assignee of Geron Corporation), which sought to overturn both decisions by the U.S. Patent and Trademark Office (USPTO) against Geron in its patent interferences.

Her love for organic gardening, cooking, healing through traditional foods, and real food - based nutritional therapies led her into a practice where she specializes in nutritional and biotherapeutic drainage therapies.

Genzyme, though, was not focusing on transgenics and decided to spin off its operation into a separate entity, Genzyme Transgenics (later renamed GTC Biotherapeutics), in which the parent still holds an equity interest.

«The preclinical work being done by the McDonald lab has been extremely informative in helping us understand that Pexa - Vec is working like a vaccine to sensitize the immune system to attack cancer,» said James Burke, CMO of SillaJen Biotherapeutics.

The transchromosomal cows used by USAMRIID collaborator SAB Biotherapeutics, Inc. offer the opportunity to produce large quantities of antibodies that are fully «human,» meaning they will not be seen as foreign antigen by the human immune system.

Board of Directors: NGM Biopharmaceuticals (Chairman), Peloton Therapeutics (Chairman), FLX Bio, Surrozen, Tenaya Therapeutics, Exonics Therapeutics, A2 Biotherapeutics

This investigational drug belongs to a new class of biotherapeutics and is a targeted immunomodulator.

Learn more about the manufacturing process of biotherapeutics and the current challenges they face in this graphic from the International Federation for Pharmaceutical Manufacturers and Associations (IFPMA).

Biotech's Encouraging Phase 2 Gut Microbiome Data «Bodes Well» for Phase 3 Source: Streetwise Reports (3/14/18) H.C. Wainwright & Co. analyst Ram Selvaraju reported the latest study findings involving this biotherapeutic firm's lead asset.

Coverage Initiated on Biotech; Analyst Says, «Time to Buy» Source: Streetwise Reports (3/14/18) Sarah Weber, an analyst with Piper Jaffray & Co., made the case for investing in this biotherapeutic development firm.

Among other applications, its innovative technological platform enables identifying and analyzing the genetic diversity of B cells to convert them into polyclonal recombinant antibodies (biotherapeutics) that improve outcomes for patients with severe diseases.

At the International Society for Stem Cell Research 2017 Annual Meeting (June 14 - 17, 2017; Boston, USA), Asterias Biotherapeutics, Inc (CA, USA) will present new 9 - month efficacy and safety data from their ongoing SCiStar Phase I / IIa trial of human embryonic stem cell - derived oligodendrocyte progenitor cells.

Founded in 2014, ImmunXperts provides immunogenicity and immune - oncology screening services, assessing all aspects of the immune responses in donors and patients, supporting its partners in the full development cycle of novel drugs, biotherapeutics and stem cell therapies.

Asterias Biotherapeutics is a growing and dynamic biotechnology company focusing in the cutting edge field of regenerative medicine.

Asterias Biotherapeutics, Inc will present new 9 - month efficacy and safety data from their ongoing Phase I / IIa trial for OPC - 1 in a workshop and poster presentation.

Jane Lebkowski, Asterias Biotherapeutics, is also interested in using stem cells as a treatment, in her case for spinal cord injury.

Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell - based therapeutics to treat neurological conditions associated with de-myelination and cellular immunotherapies to treat cancer.

Asterias Biotherapeutics is seeking a talented and dynamic scientist for a Senior Scientist position in the Regenerative Medicine and Immune - oncology Product Development team.